Trial to Assess the Efficacy of F598 in Preventing an Experimental Urethral Infection With N. Gonorrhoeae in Healthy Males
Clinical trial NCT03222401 · TERMINATED
Trial details
- NCT number
- NCT03222401
- Sponsor
- Alopexx Pharmaceuticals, LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-29
- Primary completion
- 2018-03-02
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.